Avinger (AVGR) Reports Q4 Loss Per Share of $33.62, Offers Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. HUM
2. ALHC
3. SPCX
4. CVS
5. T
6. UNH
7. AXP
8. TMUS
9. VZ
10. RTX

Go back to Avinger (AVGR) Reports Q4 Loss Per Share of $33.62, Offers Guidance

Avinger, Inc. Announces Fourth Quarter and Full Year 2014 Results

March 12, 2015 4:05 PM EDT

REDWOOD CITY, Calif., March 12, 2015 (GLOBE NEWSWIRE) -- Avinger, Inc., (Nasdaq: AVGR) a developer and manufacturer of image-guided, catheter-based systems for the treatment of peripheral arterial disease (PAD) and pioneer of the lumivascular approach to treating vascular disease, today reported financial results for the fourth quarter and year ended December 31, 2014.

Recent Highlights

Completed enrollment in VISION, a 133-patient clinical trial designed to evaluate the safety and efficacy of Pantheris, Avinger's image-guided atherectomy device, which allows physicians to precisely remove arterial plaque in PAD patients. Completed an initial public offering of five million... More